

Nearly half of Americans between the ages of 18 and 59 are infected with this sexually transmitted virus, according to a new report from the National Center for Health Statistics.
The good news: More than 90% of HPV infections are cleared by the body within 2 years. The immune system may be just part of this action.
The very bad news is that if they linger, the nasty types (HPV-16 and 18) are responsible for most of the 30,000 new cases of cancer (cervix, vagina, penis, anus and throat) each year. New vaccines can prevent the infection if young people are inoculated early enough.
A thorough review of that possibility appeared recently in Microbiome titled: The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Author Anita Mitra of Imperial College in London and her colleagues wrote:
“There is emerging evidence which leads us to conclude that increased diversity of vaginal microbiota combined with reduced relative abundance of Lactobacillus spp. is involved in HPV acquisition and persistence and the development of cervical precancer and cancer.”
Several studies explored a role for synbiotics. One such study looked at 54 women with an HPV+low-grade squamous intraepithelial lesion.
One group received a daily probiotic drink for 6 weeks while control group received none.
Results:
“Pre- and probiotics clearly present an enticing novel therapeutic approach to this disease, because they are cheap, easy to administer, with a low side effect profile, unlike the current gold standard treatment for high-grade CIN, which involves a surgical method that carries significant risk to future reproductive outcomes.”
